What Orthopedic Executives Said About 2Q21

The second quarter of 2021 brought continued market recovery from the COVID surge of late-2020. Most players exceeded performance expectations but cautioned that the third quarter would likely slow down due to seasonality and the Delta variant. Beyond those market dynamics, commentary from executives at public orthopedic companies also focused on...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us